JP2014518849A5 - - Google Patents

Download PDF

Info

Publication number
JP2014518849A5
JP2014518849A5 JP2014506576A JP2014506576A JP2014518849A5 JP 2014518849 A5 JP2014518849 A5 JP 2014518849A5 JP 2014506576 A JP2014506576 A JP 2014506576A JP 2014506576 A JP2014506576 A JP 2014506576A JP 2014518849 A5 JP2014518849 A5 JP 2014518849A5
Authority
JP
Japan
Prior art keywords
seq
polypeptide
composition
amino acid
effective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014506576A
Other languages
English (en)
Japanese (ja)
Other versions
JP6139509B2 (ja
JP2014518849A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/034456 external-priority patent/WO2012145630A2/en
Publication of JP2014518849A publication Critical patent/JP2014518849A/ja
Publication of JP2014518849A5 publication Critical patent/JP2014518849A5/ja
Application granted granted Critical
Publication of JP6139509B2 publication Critical patent/JP6139509B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014506576A 2011-04-21 2012-04-20 グラム陽性細菌を検出および処置するためのＳｔｒｅｐｔｏｃｏｃｃｕｓバクテリオファージリシン Expired - Fee Related JP6139509B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161477836P 2011-04-21 2011-04-21
US61/477,836 2011-04-21
PCT/US2012/034456 WO2012145630A2 (en) 2011-04-21 2012-04-20 Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016095441A Division JP6284976B2 (ja) 2011-04-21 2016-05-11 グラム陽性細菌を検出および処置するためのＳｔｒｅｐｔｏｃｏｃｃｕｓバクテリオファージリシン

Publications (3)

Publication Number Publication Date
JP2014518849A JP2014518849A (ja) 2014-08-07
JP2014518849A5 true JP2014518849A5 (https=) 2015-06-11
JP6139509B2 JP6139509B2 (ja) 2017-05-31

Family

ID=47042182

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2014506576A Expired - Fee Related JP6139509B2 (ja) 2011-04-21 2012-04-20 グラム陽性細菌を検出および処置するためのＳｔｒｅｐｔｏｃｏｃｃｕｓバクテリオファージリシン
JP2016095441A Active JP6284976B2 (ja) 2011-04-21 2016-05-11 グラム陽性細菌を検出および処置するためのＳｔｒｅｐｔｏｃｏｃｃｕｓバクテリオファージリシン
JP2017130341A Expired - Fee Related JP6587655B2 (ja) 2011-04-21 2017-07-03 グラム陽性細菌を検出および処置するためのＳｔｒｅｐｔｏｃｏｃｃｕｓバクテリオファージリシン
JP2018175907A Expired - Fee Related JP6735796B2 (ja) 2011-04-21 2018-09-20 グラム陽性細菌を検出および処置するためのＳｔｒｅｐｔｏｃｏｃｃｕｓバクテリオファージリシン

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2016095441A Active JP6284976B2 (ja) 2011-04-21 2016-05-11 グラム陽性細菌を検出および処置するためのＳｔｒｅｐｔｏｃｏｃｃｕｓバクテリオファージリシン
JP2017130341A Expired - Fee Related JP6587655B2 (ja) 2011-04-21 2017-07-03 グラム陽性細菌を検出および処置するためのＳｔｒｅｐｔｏｃｏｃｃｕｓバクテリオファージリシン
JP2018175907A Expired - Fee Related JP6735796B2 (ja) 2011-04-21 2018-09-20 グラム陽性細菌を検出および処置するためのＳｔｒｅｐｔｏｃｏｃｃｕｓバクテリオファージリシン

Country Status (12)

Country Link
US (7) US9034322B2 (https=)
EP (2) EP2699253B1 (https=)
JP (4) JP6139509B2 (https=)
CN (4) CN115887627A (https=)
AU (3) AU2012245357B2 (https=)
CA (1) CA2833409A1 (https=)
DK (1) DK2699253T3 (https=)
ES (1) ES2682670T3 (https=)
HK (2) HK1244503A1 (https=)
IL (4) IL228869B (https=)
MX (4) MX370442B (https=)
WO (1) WO2012145630A2 (https=)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3604339B1 (en) 2011-01-14 2021-03-10 The Regents Of The University Of California Therapeutic antibodies against ror-1 protein and methods for use of same
EP2699689A4 (en) * 2011-04-21 2014-12-17 Univ Utrecht Holding Bv STREPTOCOCCUS BACTERIOPHAGEN LYSINE FOR THE TREATMENT OF GRAM-POSITIVE BACTERIA IN PETS AND UTILITIES
NL2007038C2 (en) * 2011-07-04 2013-01-07 Vereniging Voor Christelijk Hoger Onderwijs System and method for predicting the viability of a body tissue in a patient, and measuring device used therein.
KR20210121313A (ko) * 2012-05-09 2021-10-07 콘트라펙트 코포레이션 그람 양성 박테리아에 대한 박테리오파지 리신과 항생제의 병용물
KR20200023521A (ko) 2012-05-09 2020-03-04 콘트라펙트 코포레이션 박테리오파지 리신을 이용한 생물막의 예방, 붕괴 및 치료
CN104073478A (zh) * 2014-06-13 2014-10-01 上海交通大学 杀灭革兰氏阳性菌的酶抗生素及其制备、用途
AU2015279705B2 (en) * 2014-06-26 2021-04-01 The Rockefeller University Acinetobacter lysins
CN104726439B (zh) * 2015-04-13 2017-11-14 武汉菲吉乐科生物科技有限公司 一种广谱的链球菌裂解酶及其应用
CN104805066B (zh) * 2015-05-18 2018-04-24 武汉菲吉乐科生物科技有限公司 一种葡萄球菌裂解酶及其应用
US20190008930A1 (en) * 2015-07-31 2019-01-10 The Regents Of The University Of California Mycobacterium lysterase: a novel treatment for acne
US20180353575A1 (en) * 2015-09-13 2018-12-13 The Rockefeller University Clostridium difficile bacteriophage lysins for detection and treatment of clostridium difficile bacteria infection
AU2016324307B2 (en) 2015-09-17 2021-10-21 Contrafect Corporation Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby
KR20190004799A (ko) 2016-05-12 2019-01-14 콘트라펙트 코포레이션 항균 폴리펩티드의 최소 억제 농도를 평가 및 탐지하기 위한 배지미량희석법
CA3069679A1 (en) * 2017-07-10 2019-01-17 Contrafect Corporation Blood component potentiation of lytic protein anti-bacterial activity and methods and uses thereof
BR112020011433A2 (pt) 2017-12-12 2020-12-01 Contrafect Corporation identificação de lisinas e seus derivados com atividade bacteriana contra pseudomonas aeruginosa
CN117866859A (zh) * 2018-01-05 2024-04-12 阿兹特拉公司 葡萄球菌属细菌的营养缺陷型菌株
KR20200124724A (ko) * 2018-02-26 2020-11-03 콘트라펙트 코포레이션 변형된 PlySs2 리신 및 이의 용도
KR102073094B1 (ko) * 2018-06-04 2020-02-04 (주)인트론바이오테크놀로지 신규한 스트렙토코커스 수이스 박테리오파지 Str-SUP-3 및 이의 스트렙토코커스 수이스 균 증식 억제 용도
KR102073086B1 (ko) * 2018-06-04 2020-02-04 (주)인트론바이오테크놀로지 신규한 스트렙토코커스 수이스 박테리오파지 Str-SUP-1 및 이의 스트렙토코커스 수이스 균 증식 억제 용도
KR102073088B1 (ko) * 2018-06-04 2020-02-04 (주)인트론바이오테크놀로지 신규한 스트렙토코커스 수이스 박테리오파지 Str-SUP-2 및 이의 스트렙토코커스 수이스 균 증식 억제 용도
JP2021533828A (ja) * 2018-08-17 2021-12-09 ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company 微小液滴を使用する抗菌薬感受性検査
US11674961B2 (en) 2018-10-12 2023-06-13 Quidel Corporation Extraction reagent for use in an assay for detection of group A Streptococcus
CA3134154A1 (en) * 2019-03-22 2020-10-01 Contrafect Corporation Method of treating infective endocarditis
EP3946609A4 (en) * 2019-04-05 2023-05-03 Contrafect Corporation LYSINE AND ITS DERIVATIVES WITH BACTERICIDAL ACTIVITY AGAINST PSEUDOMONAS AERUGINOSA IN THE PRESENCE OF HUMAN SERUM
EP3980049A4 (en) * 2019-04-11 2023-07-19 Contrafect Corporation METHOD OF TREATMENT AND PREVENTION OF BONE AND JOINT INFECTIONS
WO2021236636A1 (en) * 2020-05-19 2021-11-25 Contrafect Corporation MODIFIED PlySs2 LYSINS AND ANTIBIOTIC COMBINATIONS FOR USE AGAINST GRAM-POSITIVE BACTERIA
US20220087266A1 (en) * 2020-09-22 2022-03-24 Mars, Incorporated Compositions and methods for controlling mycotoxin production
CN114480299B (zh) * 2020-10-27 2023-08-29 暨南大学 一种蜡样芽胞杆菌噬菌体及其应用
AU2021387969A1 (en) * 2020-11-25 2023-06-22 Laboratory Corporation Of America Holdings Methods and systems for the detection of microorganisms using infectious agents
CN112760312B (zh) * 2021-01-20 2022-06-17 华中农业大学 一种裂解革兰氏阳性菌的裂解酶plyssX609及其应用
WO2022159989A1 (en) * 2021-01-25 2022-07-28 Avails Medical, Inc. Apparatus, systems, and methods for preparing an output sample with aeration
WO2023049747A1 (en) * 2021-09-22 2023-03-30 Elanco Us Inc. Streptococcus suis lytic enzyme compositions and methods of use thereof
KR102742550B1 (ko) * 2022-07-26 2024-12-18 주식회사 인트론바이오테크놀로지 연쇄상구균에 대하여 용균 활성을 갖는 항균단백질
WO2024059184A1 (en) * 2022-09-16 2024-03-21 The Johns Hopkins University Machine learning systems and related aspects for the detection of disease states
CN116640754B (zh) * 2023-07-21 2023-10-10 临沂大学 一种链球菌前噬菌体裂解酶lys224及应用
CN117051043B (zh) * 2023-10-11 2024-01-30 圆因(北京)生物科技有限公司 一种基于环状rna编码耐甲氧西林金黄色葡萄球菌内溶素及其应用
CN118272361B (zh) * 2024-05-13 2026-01-09 内蒙古农业大学 一种发酵粘液乳杆菌噬菌体裂解酶LysLFP01及其制备方法和应用

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3278378A (en) 1962-04-19 1966-10-11 Schindler Charles Alvin Staphylococcus-derived antibiotic
US3398056A (en) 1964-07-10 1968-08-20 Mead Johnson & Co Process for producing lysostaphin by fermentation
US3594284A (en) 1968-06-04 1971-07-20 Mead Johnson & Co Lysostaphin fermentation with accelerated time cycle
US3654090A (en) 1968-09-24 1972-04-04 Organon Method for the determination of antigens and antibodies
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US4016043A (en) 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
NZ201918A (en) 1981-09-18 1987-04-30 Genentech Inc N-terminal methionyl analogues of bovine growth hormone
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
EP0163696B1 (en) 1983-11-14 1992-11-25 Columbia Laboratories, Inc. Use of a bioadhesive
DE229046T1 (de) 1985-03-30 1987-12-17 Marc Genf/Geneve Ballivet Verfahren zum erhalten von dns, rns, peptiden, polypeptiden oder proteinen durch dns-rekombinant-verfahren.
AU8108587A (en) 1986-10-08 1988-05-06 David Bernstein Method for exposing group a streptococcal antigens and an improved diagnostic test for the identification of group a streptococci
US4948580A (en) 1988-12-08 1990-08-14 E. R. Squibb & Sons, Inc. Muco-bioadhesive composition
JPH02258718A (ja) 1989-03-31 1990-10-19 Nippon Kayaku Co Ltd ペースト状基剤及び製剤
US5264563A (en) 1990-08-24 1993-11-23 Ixsys Inc. Process for synthesizing oligonucleotides with random codons
ES2156149T3 (es) 1992-12-04 2001-06-16 Medical Res Council Proteinas de union multivalente y multiespecificas, su fabricacion y su uso.
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US5554380A (en) 1994-08-04 1996-09-10 Kv Pharmaceutical Company Bioadhesive pharmaceutical delivery system
US5863560A (en) 1996-09-11 1999-01-26 Virotex Corporation Compositions and methods for topical application of therapeutic agents
US5942243A (en) 1996-11-12 1999-08-24 Polytherapeutics, Inc. Mucoadhesive compositions for administration of biologically active agents to animal tissue
US20060292135A1 (en) * 1997-10-31 2006-12-28 Lawrence Loomis Use of bacterial phage-associated lysing proteins for preventing and treating bacterial infections in humans, animals and fowl
US6254866B1 (en) 1997-10-31 2001-07-03 New Horizons Diagnostics Corporation Use of phage associated lytic enzymes for treating bacterial infections of the digestive tract
US6248324B1 (en) 1997-10-31 2001-06-19 Vincent Fischetti Bacterial phage associated lysing enzymes for treating dermatological infections
US5997862A (en) 1997-10-31 1999-12-07 New Horizons Diagnostics Corporation Therapeutic treatment of group A streptococcal infections
US6264945B1 (en) 1997-10-31 2001-07-24 Vincent A Fischetti Parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections
CN1352567A (zh) * 1999-02-25 2002-06-05 新眼界诊断公司 预防性和治疗性治疗链球菌感染的方法
EP1162994A4 (en) 1999-02-25 2004-12-29 New Horizons Diagnostics Inc COMPOSITION FOR THE PROPHYLACTIC AND THERAPEUTIC TREATMENT OF STREPTOCOCCAL INFECTIONS
US6056955A (en) 1999-09-14 2000-05-02 Fischetti; Vincent Topical treatment of streptococcal infections
AU2003291614A1 (en) 2002-05-17 2004-04-08 New Horizons Diagnostics Corporation Identification of a phage associated lytic enzyme to rapidly and specifically detect and kill bacillus anthracis
US8326388B2 (en) 2002-10-31 2012-12-04 Toshiba Medical Systems Corporation Method and apparatus for non-invasive measurement of living body characteristics by photoacoustics
AU2003291365B2 (en) * 2002-11-07 2009-06-11 Synergy America, Inc. Compositions and methods for treating or preventing pneumococcal infection
WO2004104213A2 (en) 2003-05-15 2004-12-02 The Rockefeller University Nucleic acids and polypeptides of c1 bacteriophage and uses thereof
US7569223B2 (en) 2004-03-22 2009-08-04 The Rockefeller University Phage-associated lytic enzymes for treatment of Streptococcus pneumoniae and related conditions
US7638600B2 (en) 2004-03-24 2009-12-29 The Rockefeller University Lytic enzymes and spore surface antigen for detection and treatment of Bacillus anthracis bacteria and spores
GB0410220D0 (en) * 2004-05-07 2004-06-09 Kirkham Lea Ann Mutant pneumolysin proteins
WO2008018854A2 (en) 2005-06-06 2008-02-14 The Rockefeller University Bactiophage lysins for bacillus anthracis
US7582291B2 (en) * 2005-06-30 2009-09-01 The Rockefeller University Bacteriophage lysins for Enterococcus faecalis, Enterococcus faecium and other bacteria
CA2620903A1 (en) * 2005-08-24 2007-03-01 The Rockefeller University Ply-gbs mutant lysins
IE20060488A1 (en) * 2006-06-29 2008-01-09 Teagasc Agric Food Dev Authori Recombinant staphylococcal phage lysin as an antibacterial agent
DE102006061002A1 (de) * 2006-12-22 2008-06-26 Profos Ag Verfahren und Mittel zur Anreicherung, Entfernung und zum Nachweis von gram-positiven Bakterien
AU2008328584A1 (en) 2007-11-26 2009-06-04 Plant Bioscience Limited Novel polypeptides having endolysin activity and uses thereof
EP2103308A1 (de) * 2008-03-20 2009-09-23 PhytoLine GmbH Verfahren zur Herstellung eines Gemisches von Bakteriophagen und deren Verwendung für die Therapie von Antibiotika-resistenten Staphylococcen
EP3263588A1 (en) 2008-07-03 2018-01-03 The Rockefeller University Isolated staphylococcus-specific soluble binding molecule
CA2736062A1 (en) * 2008-07-24 2010-01-28 The United State Of America, As Represented By The Secretary Of Agricuure Triple acting antimicrobials that are refractory to resistance development
GB0815484D0 (en) * 2008-08-26 2008-10-01 Univ Leuven Kath Antibacterial agents
KR101016918B1 (ko) * 2009-01-08 2011-02-25 주식회사 인트론바이오테크놀로지 박테리아 특이적 넓은 항균 활성을 갖는 신규한 리신 단백질
WO2011091412A1 (en) * 2010-01-25 2011-07-28 Alere Scarborough, Inc. A25 bacteriophage lysin
EP2699689A4 (en) * 2011-04-21 2014-12-17 Univ Utrecht Holding Bv STREPTOCOCCUS BACTERIOPHAGEN LYSINE FOR THE TREATMENT OF GRAM-POSITIVE BACTERIA IN PETS AND UTILITIES

Similar Documents

Publication Publication Date Title
JP2014518849A5 (https=)
Tagg Prevention of streptococcal pharyngitis by anti-Streptococcus pyogenes bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius
E. Greber et al. Antimicrobial peptides under clinical trials
Nuti et al. Antimicrobial peptides: a promising therapeutic strategy in tackling antimicrobial resistance
KR102419616B1 (ko) 항균 요법
Schuch et al. Combination therapy with lysin CF-301 and antibiotic is superior to antibiotic alone for treating methicillin-resistant Staphylococcus aureus–induced murine bacteremia
Wang et al. A phage lysin fused to a cell-penetrating peptide kills intracellular methicillin-resistant Staphylococcus aureus in keratinocytes and has potential as a treatment for skin infections in mice
CA2981996C (en) Broad spectrum of streptococcus lyase and use thereof
EP3349781A2 (en) Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby
RU2013117275A (ru) Бактериофаги, фаговые пептиды и способы их применения
Simoes et al. Novel antibacterial agents: an emergent need to win the battle against infections
Ashby et al. Cationic antimicrobial peptides as potential new therapeutic agents in neonates and children: a review
Mechkarska et al. An analog of the host-defense peptide hymenochirin-1B with potent broad-spectrum activity against multidrug-resistant bacteria and immunomodulatory properties
JP2013541333A5 (https=)
RU2014149351A (ru) Комбинации лизина бактериофага и антибиотика против грам-положительных бактерий
Fischetti Lysin therapy for Staphylococcus aureus and other bacterial pathogens
JP2006507270A (ja) 感染症および他の疾患の治療
Ciandrini et al. Antimicrobial activity of different antimicrobial peptides (AMPs) against clinical methicillin-resistant Staphylococcus aureus (MRSA)
JPH11508265A (ja) 抗生物質抵抗性グラム陽性細菌の制御および感染治療の方法
JP2013523718A5 (https=)
US20150087579A1 (en) Antimicrobial peptides
CN112867398A (zh) 溶素及其衍生物使金黄色葡萄球菌和革兰氏阳性菌对抗生素重新敏感
CN107177580B (zh) 一种广谱新型嵌合裂解酶GBS-PlySb及其编码基因和应用
JP2015515280A5 (https=)
CN107022539B (zh) 一种链球菌广谱嵌合裂解酶GBS-V12b及其编码基因和应用